Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Smith & Nephew Plc (SN-.LN)

Smith & Nephew Plc (SN-.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Smith & Nephew Plc Hatters Lane Building 5, Croxley Park Watford Hertfordshire WD18 8YE GBR

https://www.smith-nephew.com P: 192-347-7100

Description:

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Key Statistics

Overview:

Market Capitalization, $K 8,538,754
Shares Outstanding, K 874,335
Annual Sales, $ 5,549 M
Annual Net Income, $ 263,000 K
Last Quarter Sales, $ 1,249 M
Last Quarter Net Income, $ 160,000 K
% of Insider Shareholders 0.29%
% of Institutional Shareholders 57.50%

Growth:

1-Year Return -22.03%
3-Year Return -37.74%
5-Year Return -38.86%
5-Year Revenue Growth 2.50%
5-Year Earnings Growth -16.84%
5-Year Dividend Growth 0.33%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm 0.30
EPS Growth vs. Prev Qtr 57.52%
EPS Growth vs. Prev Year -9.28%
Annual Dividend Rate, $ 0.37
Annual Dividend Yield 3.10%
Most Recent Dividend 0.231 on 03/28/24
Next Ex-Dividends Date 03/28/24
Dividend Payable Date 05/22/24
Dividend Payout Ratio 123.82%
Most Recent Split 9-11 on 08/07/00

SN-.LN Ratios

Ratio
Price/Earnings ttm 40.52
Price/Earnings forward 12.39
Return-on-Equity % 5.02%
Return-on-Assets % 2.64%
Profit Margin % 4.74%
Debt/Equity 0.44
Price/Sales 1.92
Price/Book 2.04
Book Value/Share 4.78
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar